Clinical Trials in Tennessee

Showing 9061-9080 of 20,239 trials

OLAParib COmbinations

NCT02576444

The primary objective of this phase II trial is to determine tumor overall response rate (ORR) in molecularly selected patients with measurable disease as assessed by the Response Evaluation Criteria in Solid Tumors (RECIST), before versus after 16 weeks of treatment across tumor types in each arm of the study.

Cancer

Joseph Paul Eder67 participantsStarted Nov 2015

New Haven, Connecticut, United States • Boston, Massachusetts, United States • Cleveland, Ohio, United States +1 more locations

TERMINATEDNA29 miles

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

NCT03618095

REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects

Aortic Valve Stenosis

Boston Scientific Corporation382 participantsStarted Jan 2019

Huntsville, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +47 more locations

OLAParib COmbinations

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Find Trials by Condition in Tennessee

Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

Formula Tolerance of Term Infants

An Extension of the TG1101-RMS201 Trial

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Primary Diagnosis Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Evaluation of GLR2007 for Advanced Solid Tumors

Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma